Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Stefano Caruso

Université de Paris Faculté de Santé

France

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Cell Biology

60%

Biostatistics

30%

Cancer Biology

80%

Hepatology

40%

Prognostic Biomarker

20%

Transcriptomic

20%

Epithelial-mesenchymal Transition

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial.

Article Link

Year:

2022

TGFβ‐induced FOXS1 controls epithelial–mesenchymal transition and predicts a poor prognosis in liver cancer

Article Link

Year:

2022

Deleting the β-catenin degradation domain in mouse hepatocytes drives hepatocellular carcinoma or hepatoblastoma-like tumor growth

Article Link

Year:

2022

Immune Profiling of Combined Hepatocellular- Cholangiocarcinoma Reveals Distinct Subtypes and Activation of Gene Signatures Predictive of Response to Immunotherapy

Article Link

Year:

2022

Artificial intelligence predicts immune and inflammatory gene signatures directly from hepatocellular carcinoma histology

Article Link

Year:

2022

Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies

Article Link

Year:

2022

Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study

Article Link

Year:

2022

LIM Homeobox-2 Suppresses Hallmarks of Adult and Pediatric Liver Cancers by Inactivating MAPK/ERK and Wnt/Beta-Catenin Pathways

Article Link

Year:

2022

Molecular Subtypes and Gene Expression Signatures as Prognostic Features in Fully Resected Clear Cell Renal Cell Carcinoma: A Tailored Approach to Adjuvant Trials

Article Link

Year:

2021

Molecular underpinnings of glandular tropism in metastatic clear cell renal cell carcinoma: therapeutic implications

Article Link

Year:

2021

Collaborators9

Maxime Meylan

Dana-Farber Cancer Institute

UNITED STATES

Emeric Dubois

Inserm u1183

FRANCE

christophe klein

INSERM

FRANCE

Cheng-Ming Sun

INSERM

FRANCE

Laurent Sulpice

university hospital of Rennes

FRANCE

Eric Letouzé

Sorbonne Université

FRANCE

Camille BOULAGNON

Université de Reims Champagne-Ardenne

FRANCE

David Gilot

Associate Professor

Université de Rennes 1

FRANCE

Veschambre Philippe

Assistant professor

FRANCE

How do I reach out?

Meet Kite AI